- Home
- CMRX vs VACH Comparison
CMRX vs VACH Comparison
Compare CMRX & VACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMRX
- VACH
- Stock Information
- Founded
- CMRX 2000
- VACH 2023
- Country
- CMRX United States
- VACH United States
- Employees
- CMRX N/A
- VACH N/A
- Industry
- CMRX Biotechnology: Pharmaceutical Preparations
- VACH
- Sector
- CMRX Health Care
- VACH
- Exchange
- CMRX Nasdaq
- VACH NYSE
- Market Cap
- CMRX 394.1M
- VACH 318.5M
- IPO Year
- CMRX 2013
- VACH 2024
- Fundamental
- Price
- CMRX $5.15
- VACH $10.12
- Analyst Decision
- CMRX Strong Buy
- VACH
- Analyst Count
- CMRX 2
- VACH 0
- Target Price
- CMRX $8.50
- VACH N/A
- AVG Volume (30 Days)
- CMRX 1.7M
- VACH 253.0
- Earning Date
- CMRX 03-07-2025
- VACH 01-01-0001
- Dividend Yield
- CMRX N/A
- VACH N/A
- EPS Growth
- CMRX N/A
- VACH N/A
- EPS
- CMRX N/A
- VACH N/A
- Revenue
- CMRX $159,000.00
- VACH N/A
- Revenue This Year
- CMRX N/A
- VACH N/A
- Revenue Next Year
- CMRX $1,690.28
- VACH N/A
- P/E Ratio
- CMRX N/A
- VACH N/A
- Revenue Growth
- CMRX N/A
- VACH N/A
- 52 Week Low
- CMRX $0.75
- VACH $9.97
- 52 Week High
- CMRX $5.53
- VACH $10.25
- Technical
- Relative Strength Index (RSI)
- CMRX 76.25
- VACH N/A
- Support Level
- CMRX $3.94
- VACH N/A
- Resistance Level
- CMRX $5.53
- VACH N/A
- Average True Range (ATR)
- CMRX 0.30
- VACH 0.00
- MACD
- CMRX 0.07
- VACH 0.00
- Stochastic Oscillator
- CMRX 78.29
- VACH 0.00
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.
About VACH VOYAGER ACQUISITION CORP.
Voyager Acquisition Corp is a blank check company.